These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 538236)

  • 21. The activation of complement components by aggregates of antibodies and their fragments.
    Dodds AW; Porter RR
    Mol Immunol; 1979 Dec; 16(12):1059-62. PubMed ID: 542202
    [No Abstract]   [Full Text] [Related]  

  • 22. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Function and genetic control of complement system (author's transl)].
    Tachibana T
    Ryumachi; 1978 Jul; 18(4):267-77. PubMed ID: 358416
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of complement by tetrathyridia of Mesocestoides corti: enhancement by antibodies from infected mice and lack of effect on parasite viability.
    Toye PG; Ey PL; Jenkin CR
    J Parasitol; 1984 Dec; 70(6):871-8. PubMed ID: 6396394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
    J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of rat complement by soluble and insoluble immune complexes of rat IgA.
    Rits M; Hiemstra PS; Bazin H; van Es LA; Daha M; Vaerman JP
    Monogr Allergy; 1988; 24():129-33. PubMed ID: 3362139
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.
    Lutz HU; Fasler S; Stammler P
    Beitr Infusionsther; 1989; 24():193-9. PubMed ID: 2481539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES).
    Saint-Remy JM; Magnusson CG; Masson PL
    J Immunol; 1983 Mar; 130(3):1341-4. PubMed ID: 6822738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of complement pathways by univalent antibody derivatives with intact Fc zones.
    Watts HF; Anderson VA; Cole VM; Stevenson GT
    Mol Immunol; 1985 Jul; 22(7):803-10. PubMed ID: 3849671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of immune complexes.
    Margni RA; Perdigón G; Manghi M; Hajos S
    Medicina (B Aires); 1979; 39(2):183-6. PubMed ID: 502828
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of the mechanism of binding of chemically modified cytophilic antibodies to macrophages.
    Thrasher SG; Cohen S
    J Immunol; 1971 Sep; 107(3):672-7. PubMed ID: 5572090
    [No Abstract]   [Full Text] [Related]  

  • 36. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the interaction of rabbit C1q with sheep and rabbit immune complexes.
    Liberti PA; Baillie RD; Milligan KF; Bausch DM
    J Immunol; 1979 Nov; 123(5):2212-9. PubMed ID: 114586
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.
    Kijlstra A; Van Es LA; Daha MR
    Immunology; 1979 Jul; 37(3):673-80. PubMed ID: 500123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of the hemolytic activity of complement on microtitration plates by the classical and alternative pathway].
    Lochman I; Lochmanová A; Tvrdik J; Machálek J
    Cesk Epidemiol Mikrobiol Imunol; 1984 Sep; 33(5):291-8. PubMed ID: 6238681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.